Introduction
Dysnatremias are commonly associated with cancer (1, 2) . Hyponatremia, already the most common electrolyte disorder, may be seen in as many as 46% of hospitalized patients in a cancer center (3) . The etiologies are myriad. Certain cancers cause a paraneoplastic syndrome of inappropriate antidiuretic hormone (SIADH). Tumor involvement, in the brain and lungs commonly, can result in SIADH as well. Certain chemotherapies elicit antidiuretic hormone (ADH) release (4) . ADH is also stimulated for nonosmotic reasons such as nausea, pain, narcotics, and hypovolemia, all of which are TBW Na In In t U U t Na TBW In t U t
where [Na] t = sodium at time t, and [Na] 0 = starting sodium. It can be expanded to any number of known inputs or outputs and is already customized to accept the clinical variables in the units that they are typically reported: TBW in liters;
[Na] t/0 , In Na+K , and U Na+K in mEq/L; In Rate and U Rate in mL/h; and, finally, time t in hours. Deriving a kinetic sodium equation is important because the treatment of the dysnatremias hinges upon the rate of correction. We err on the side of increasing the serum sodium at no faster than +8-10 mEq/L in 24 h for hyponatremia that is assumed to be chronic (>48 hours) unless proven otherwise (13) (14) (15) (16) (17) (18) . We aim for a similar rate of correction for hypernatremia, although some leeway is given for a faster rate of correction in the first 24 hours (19, 20) . At the very least, doctors want to prescribe a therapy that keeps the dysnatremia from worsening. This situation may arise when normal saline (NS) is given in the setting of SIADH (13, (21) (22) (23) (24) . Correcting a dysnatremia at close to the desired rate can be achieved in a more technical way with the kinetic sodium equation (11, 12) .
One variable that doctors have the most control over is the fluid rate (25) (26) (27) . Fl Rate specifies how fast a fluid, such as NS or dextrose 5% water (D5W), should be infused. These prescriptions must compensate for the variables out of our control, such as urine [electrolyte] and urine flow rate, in such a way as to correct the serum sodium at a safe rate (10, (28) (29) (30) . Thus, we solved the kinetic sodium equation explicitly for Fl Rate .
Methods

Incorporating time
Physicians are familiar with the role of time, because they prescribe intravenous (IV) fluids at a rate, usually in units of mL/h. Multiplying the rate and time by the fluid concentration yields a quantity of solutes to add to the numerator of the sodium equation. Likewise, multiplying rate and time yields the volume of water to add to the denominator. The urine flow rate is also coded in terms of time. The kidney produces urine at more or less a continuous rate. That is belied by the episodic nature of urination, since urine accumulates in the bladder to be expelled in a large volume when it is convenient (unless there is a Foley catheter). But the sum of all the urine volumes in a day can give an accurate measure of the urine production rate. That information is found in the input/output section of the hospital chart. Knowing the urine flow rate, Out Rate , we can deduce that the urinary loss of cationic solutes equals Out Na+K Out Rate t, where Out Na+K = urinary [Na+K], and t = time. The volume of urinary water is Out Rate t.
Similarly, oral intake of fluids can be converted into a continuous rate. Although the drinking of fluids is truly episodic, we can pretend that the total volume drunk in 1 day yields the average rate of fluid consumption for the purposes of the kinetic equation. Physicians are also familiar with the concept of average fluid rate, because they prescribe fluid restriction in terms of mL/day. In In t + ⋅ ⋅ gives the oral ingestion of Na/K to add to the numerator of the kinetic sodium equation, also assuming complete absorption.
Behind the math
Having codified the net balance of Na/K and water from the various inputs (IV fluids, oral intake, salt tablets, etc.) and outputs (urine, gastrointestinal, insensible, etc.) in terms of time, we can use conservation of mass to assert that the rate of change in the Na/K amount is equal to the rate of Na/K coming in minus the rate of Na/K going out. The solution to that differential equation 
Spreadsheet
Once the principle of sodium kinetics is understood, the calculations can be done on a spreadsheet or other programmable app. This portability is especially helpful on the wards. To show how the equation may be used in practice, we entered the relevant clinical data into the spreadsheet and used the result to take care of real patients with dysnatremia.
Results
Normal saline
L.P. is a 63-year-old woman with metastatic epithelioid hemangioendothelioma, who is being treated with cyclophosphamide. Her hyponatremia was of relatively recent onset, so it was attributed to cyclophosphamide-induced SIADH. Nephrology was consulted because the serum sodium was slowly decreasing despite her receiving IV fluids.
Gathering data
Her body weight was 54.4 kg. If roughly half of the weight is total body water (TBW), then we can input 27 L. A recent urine Na was 83 mEq/L and urine K was 71.0 mEq/L for a sum of 154 mEq/L. Urine output was charted as 600 mL in 24 hours for a rate of 25 mL/h. She was receiving IV fluid in the form of D5NS + 20 mEq/L KCl for an [Na+K] of 174 mEq/L. The infusion rate was 75 mL/h. She was nil by mouth and was not taking salt tablets.
Goal and analysis
We wished to increase her serum sodium from 120 to 124 mEq/L over 24 hours. The current IV fluid was acceptably more hypertonic compared to her serum sodium of 120 mEq/L, so it was decided to simply adjust the infusion rate. The kinetic sodium spreadsheet was generated as follows ( Fig. 1) .
To replicate the spreadsheet answer, the equation would be populated as follows: 
The calculation said that an additional 30 mL/h of the treatment fluid was needed, going from 75 to 105 mL/h. We settled on changing the prescribed rate to 100 mL/h.
Reality check and commentary
In reality, the serum sodium went from 120 mEq/L at 00:01 to 124 mEq/L at 00:41 the next day. NS is often given to treat hyponatremia, as NS is hypertonic compared to any level of hyponatremia (31) . However, NS can occasionally exacerbate hyponatremia, especially when SIADH is severe (13, 22, 32) , as was the case here. The risk of a paradoxical lowering of sodium with NS is greater the more concentrated the urine electrolytes are (154 mEq/L) versus the serum sodium (120 mEq/L), so our patient was at risk (21, 23, 33) . It took an increase in the rate of D5NS + 20 mEq/L KCl to overcome the SIADH and start to raise the serum sodium (31) .
Hypertonic saline
J.A. is a 58-year-old woman with small cell lung cancer and paraneoplastic SIADH. She was hospitalized for hyponatremia to a serum sodium of 117 mEq/L. When fluid restriction to 1 L/day did not improve her [sodium], the nephrology consult team decided to try 3% saline.
Gathering data
The patient's body weight was 65.4 kg, so TBW was inputted as 33 L. The urine Na was 147 mEq/L. Urine K was not checked, but based on the urine osmolality of 393 mOsm/kg H 2 O the urine K could be 49.5 mEq/L at most, if no urine urea nitrogen or glucose was present. We decided to input the urine [Na+K] as 155 mEq/L. Urine output was recorded as 500 mL over the past 24 h for a rate of ~20.8 mL/h. She was not receiving IV fluids. No oral intake was assumed, and she was not taking salt tablets. 
Goal and analysis
The goal was to raise the serum sodium from 117 to 125 mEq/L in 24 hours. Since 3% saline was being used, the treatment fluid [Na+K] was entered as 513 mEq/L. The spreadsheet was filled in (Fig. 2) , and based on the calculation 3% saline was ordered at 30 mL/h.
Reality check and commentary
In reality, the sodium went from 117 mEq/L at 05:15 to 122 mEq/L at 07:53 the next day. To be fair, 3% saline was not begun until about 15:00 of day 1, and a little less than 24 hours later at 12:21 of day 2 (~4.5 h after the 07:53 draw) the serum sodium was 125 mEq/L. Hypertonic saline was stopped.
D5W
T.C. is a 73-year-old man with a clival chordoma that was causing central diabetes insipidus leading to hypernatremia, with serum sodium of 152 mEq/L. He was receiving D5W at 100 mL/h, but the sodium lowering had stalled, so the renal fellow was planning to empirically titrate the D5W to 110 mL/h.
Gathering data
The patient's body weight was 78.7 kg. This was multiplied by 0.6 to get ~47 L for the TBW. The urine Na was 51 mEq/L and urine K was 11.0 mEq/L. The urine output was recorded as 3,120 mL in 24 hours for a rate of 130 mL/h. As mentioned above, D5W with an [Na+K] of 0 mEq/L was being infused at 100 mL/h. The oral intake of water was estimated as 150 mL in 24 hours for a rate of 6.25 mL/h.
Goal and analysis
The fellow wanted to bring the [Na] down from 152 to 146 mEq/L in 24 hours. Setting the treatment fluid [Na+K] to zero for D5W, we obtained the following spreadsheet result ( Fig. 3 ). Based on the calculation, the fellow convinced the intensive care unit team to increase the D5W rate from 100 to 150 mL/h.
Reality check and commentary
In reality, in the next ~24 hours from 06:13 to 07:01 the next day, the serum sodium went from 152 to 144 mEq/L. As an aside, the rate calculation for D5W could have been extrapolated to free water flushes, as both are effectively salt free. However, with flushes, the gain of water is not as certain as with the IV infusion.
Salt tablets
The kinetic sodium equation can be adapted to calculate the amount of salt tablets to give. 
Then multiply by the molecular weight of NaCl, 58.5, to get the salt tablet rate in mg/h, assuming that all the tablets are fully absorbed. L.G. is an 81-year-old female with melanoma, newly metastatic to the brain with some of the lesions being hemorrhagic. She was diagnosed with hyponatremia due to SIADH. Her serum sodium was 131 mEq/L when nephrology was consulted. A woman with small cell lung cancer, hyponatremia, and the syndrome of inappropriate antidiuretic hormone was to be treated with 3% NaCl intravenous fluid. With the solicited data entered, the kinetic sodium spreadsheet calculated that the 3% saline should be infused at ~30 mL/h to raise the serum sodium from 117 to 125 mEq/L in 24 hours. Fig. 3 -Dextrose 5% in water (D5W) was being given to a man with central diabetes insipidus and hypernatremia, but the serum sodium was not improving. The kinetic sodium spreadsheet informed the physicians that the D5W infusion rate should be increased by ~50 mL/h to achieve the desired lowering of sodium.
Gathering data
Her body weight was 98.5 kg, so we could input 49 L for TBW. The urine Na was 76 mEq/L and the urine K was 34.7 mEq/L for a sum of 110.7 mEq/L. Urine output was recorded as 1,570 mL over the past 24 hours for a rate of ~65.4 mL/h. No IV fluids or salt tablets were being given. She was drinking approximately 700 mL per day, so the oral intake of fluid was at ~29.2 mL/h.
Goal and analysis
We decided to treat the hyponatremia with salt tablets. The goal was to raise the serum sodium from 131 to 133 mEq/L in a day. The kinetic sodium spreadsheet (Fig. 4) gave the salt tablet rate at ~380.5 mg/h, which, over 24 hours, would be ~9,131 mg. Thus, the patient was prescribed NaCl tablets at 3 g by mouth 3 times a day.
Reality check and commentary
In reality, her serum sodium went from 131 mEq/L at 04:19 to 134 mEq/L at 04:37 the following day. This exercise shows that the required sodium load can far exceed a typical starting dose of NaCl, like 1 gram by mouth 3 times a day. There is even a precedent for salt tablets being given hourly (34) . Inadvertent underdosing may explain why salt tablets may not seem to work at times in hyponatremia (35) .
Water diuresis
So far, the urine [Na+K] was assumed to be constant over the time period of the analysis, usually 24 hours. The assumption worked well enough, as the kinetic sodium equation yielded sensible prescriptions that, when acted upon, nearly achieved the desired serum sodium. In reality, the urine [Na+K] can fluctuate, but in the cases above it probably oscillated around an average value. That average [Na+K] ends up being measured by the laboratory due to the way that urine is pooled prior to specimen collection, whether in the patient's bladder or in a Foley bag. An average U Na+K can be fairly consistent in the short-term, such as in SIADH (36), but sometimes the average U Na+K can change drastically. In the following case, SIADH was treated with tolvaptan, resulting in an abrupt water diuresis. This scenario requires a modification in how the kinetic equation is used.
S.S. is a 73-year-old female who has small cell lung cancer of the right upper lobe with a secondary malignant neoplasm of the liver and intrahepatic bile duct. Nephrology was consulted for hyponatremia that was due to SIADH, despite being on 7.5 mg tolvaptan daily as an outpatient. She was admitted for a [sodium] that had decreased to the 120s mEq/L range.
Gathering data
Her body weight was 48 kg for a TBW of ~24 L. Serum sodium was 122 mEq/L at 03:16. The urine Na was 146 mEq/L and the urine K was 24.0 mEq/L, measured at 09:02. Urine flow was 25 mL/h. Given the concentrated urine, nephrology recommended that an additional 15 mg tolvaptan be given that day (total 22.5 mg). The primary team also ordered salt tablets at 1,000 mg by mouth 3 times a day. An aquaresis ensued, and the urine Na dropped to 54 mEq/L while the urine K dropped to 17.0 mEq/L. Urine flow increased to 65 mL/h.
Goal and analysis
Instead of a well-defined IV fluid, tolvaptan was the therapy, and we lacked control over its eventual effect on the urine [Na+K] and the flow rate. We could not aim for a desired sodium, but we could still use the kinetic equation retrospectively to see how close it came to the actual [sodium]. Tolvaptan has a rapid onset and sustained action (37) . The patient probably had diluted urine and increased flow for the bulk of the time period. Thus, for an abrupt water diuresis, the modification of the kinetic equation, in this case, was to input the post-tolvaptan urinary parameters. The aquaresis here was purposely induced by a V2-receptor antagonist (38, 39) , but other cases can be triggered by hypertonic saline (30) .
Reality check and commentary
In reality, the patient's sodium went from 122 mEq/L at 03:16 to 126 mEq/L at 19:57. If we enter the actual 126 mEq/L for the ending [sodium] and the actual 16.7 hours for the time, the kinetic equation should report that no additional treatment is needed. The infusion rate should be close to zero for any IV fluid we choose to prescribe (Fig. 5 ). NS is shown, but similar results are seen with 3% saline or salt tablets (not shown).
Using the equation prospectively, clinicians do not have the benefit of knowing the future urine [Na+K] or the urine flow rate. However, if these urinary parameters are anticipated to change quickly and durably to their future values, we can enter our best educated guesses on the effect of tolvaptan, for example. As this case demonstrates, entering the predicted (dilute) urine values is preferable for an acute change in renal response. If the pre-tolvaptan (concentrated) urine 
Conclusions
Dysnatremia frequently warrants nephrology consultation at cancer centers and hospitals in general. However, the day-to-day treatments by the primary team and the recommendations by nephrology vary widely. When serum sodium goals are not achieved and IV fluids need to be titrated, we can make sound judgment on how to adjust the infusion rate qualitatively, up or down. However, quantitatively, we tend to change the infusion rate in multiples of 5 mL/h. A gradual path to improvement may be indicated, but it could prolong a hospital stay, at best, or actually set the patient back, at worst (e.g., NS paradox in SIADH). We can do better from a quantitative standpoint by understanding the basic sodium equation and utilizing the formulas derived from these first principles to guide our therapies (10, 11, 25) .
The kinetic sodium equation is also based on the same fundamental physiology and would yield the same answers as the existing formulas. However, our equation explicitly incorporates time, which will elevate the role of the rate of sodium correction. Previous equations took the volume and composition of IV fluids (25) , paired with urinary parameters (10) , and then calculated how much the serum sodium would change. If it was too much or too little, the infusion rate was adjusted proportionally, which was not necessarily an easy computation. For treatment purposes, clinicians would likely prefer the equations to work in the opposite direction. Knowing the serum sodium to aim for, they would like to know the IV fluid volume to give (11) . Our equation refines that further and reports the IV fluid rate, which is what the hospital orders require, while also taking into consideration the rate of sodium correction.
Admittedly, the kinetic sodium equation appears more complex than past formulas. However, the complexity is necessary, in part, to accommodate all of the potential sources of inputs and outputs that affect the cationic solute-to-water balance. When these multiple sources are not included, our equation reduces to the Adrogué-Madias formula, for example (15, 26) . Besides, the complexity does not have to be intimidating, as the kinetic equation can be shrouded behind a user-friendly spreadsheet or an app that could make the adoption curve less steep. Also, by varying the input values one-at-a-time (e.g., TBW, correction rate, urine [Na+K], urine flow rate, etc.), our fellows have been able to develop an intuition for how the IV fluid prescription ought to change.
The renal response to dysnatremia is not static. The urine [Na+K] and flow rate measured at one point in time do not always remain around those values. However, these fluctuations are represented in aggregate by the average values of the urinary parameters. In practice, the averages are the data being entered into the kinetic equation, because (i) urine is mixed to give the average U Na+K ; and (ii) the charted daily urine volume divided by 24 hours is the average U Rate . The use of averages results in less skewing and helps the accuracy of the kinetic equation. In a sense, the average U Na+K and U Rate are also being used in the case of water diuresis. However, the U Na+K and U Rate during an aquaresis will not be measured until a few hours later. The best we can do is to predict what the average values will be, and the kinetic spreadsheet is equipped to run the worst-case and other "what-if?" scenarios. Our predictive approach is consistent with other strategies to avoid too rapid a correction of hyponatremia (30) and to mitigate the risk of osmotic demyelination (40) (41) (42) .
The kinetic and other sodium equations do not eliminate the need for vigilant monitoring of serum sodium and urinary parameters. Correction may not proceed as expected, because some variables may have changed or unknown variables may have a significant effect. Nevertheless, the most current or predicted clinical data can be entered into the kinetic equation to see how treatment should be adjusted. The calculations and aggregation of data are simplified by the use of a spreadsheet, which gives immediate and actionable results that facilitate the decisions on IV fluid orders during rounds. We hope that the kinetic sodium equation will assist in the management of dysnatremia in cancer centers and beyond.
Appendix
Fundamental differential equation
The kinetic sodium model as a function of time flows from the mass balance principle that the rate of change in the bodily Na/K content equals the rate of Na/K inputs minus the rate of Na/K outputs. For example, a dynamic equilibrium is achieved when In Na+K In Rate (units of mEq/h) matches the Fig. 5 -Water diuresis. Tolvaptan was being given to treat hyponatremia and the syndrome of inappropriate antidiuretic hormone, so an abrupt aquaresis was anticipated. As expected, the urine became diluted and the urine volume increased. Over the 16.7 hours, her serum sodium had increased from 122 to 126 mEq/L. In retrospect, this increase is nearly what the kinetic sodium equation would predict if the water diuresis were continued throughout the time period. The observed rise in serum sodium could be entirely explained by the effect of tolvaptan, which is supported by the kinetic sodium spreadsheet. It shows that 0.9% saline would only need to be given at ~1 mL/h. Although not shown, other intravenous fluids or salt tablets would also be calculated at close to 0.
Out Na+K Out Rate , and then the net rate of change in the total body Na+K content equals zero.
The Therapeutically, physicians want to be able to control where a patient's serum sodium will be after a certain time. We can add a "treatment fluid" and solve for its administration rate. This is the mathematical equivalent of a physician choosing an IV fluid like NS, and then calculating the NS infusion rate, in theory, to achieve the desired change in the serum sodium at a safe correction rate. , and urine flow rate) and the clinical circumstances (e.g., ongoing IV fluids in terms of their In Na+K and In Rate ). The concept of the therapeutic fluid can be adapted to the prescribing of salt tablets. Finally, the serum sodium is also affected by hyperglycemia (12) and the pool of osmotically inactive Na/K (43-46); however, modeling these effects is beyond the scope of the present work.
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